Picture of Boiron SA logo

BOI Boiron SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Momentum

Relative Strength (%)
1m+3.4%
3m+14.85%
6m+29.7%
1yr+25.83%
Volume Change (%)
10d/3m-23.85%
Price vs... (%)
52w High-9.67%
50d MA-4.7%
200d MA+6.04%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.73
PEG Ratio (f)0.91
EPS Growth (f)19.38%
Dividend Yield (f)2.8%
Valuation (ttm)IndustryMarket
Price to Book Value1.43
Price to Tang. Book1.9
Price to Free Cashflow15.85
Price to Sales1.46
EV to EBITDA6.21

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital12.63%
Return on Equity9.9%
Operating Margin14.92%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue€m617.54604.21557.12513.58455.2514.2523.83-5.82%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+3.63-21.58-29.14-38.31+11.61+67.58+8.82n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Boiron SA EPS forecast chart

Profile Summary

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
January 1st, 1967
Public Since
March 25th, 1991
No. of Employees
2,794
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
17,368,137

BOI Share Price Performance

Upcoming Events for BOI

Similar to BOI

Picture of AB Science SA logo

AB Science SA

fr flag iconEuronext - Paris

Picture of Advicenne SA logo

Advicenne SA

fr flag iconEuronext - Paris

Picture of Aelis Farma SA logo

Aelis Farma SA

fr flag iconEuronext - Paris

Picture of Biocorp Production SA logo

Biocorp Production SA

fr flag iconEuronext - Paris

Picture of DBV Technologies SA logo

DBV Technologies SA

fr flag iconEuronext - Paris

FAQ

Or unlock with your email

Or unlock with your email